ATE451618T1 - Verfahren zur identifizierung von epitopen in zusammenhang mit immunogenität bei biopharmazeutika - Google Patents

Verfahren zur identifizierung von epitopen in zusammenhang mit immunogenität bei biopharmazeutika

Info

Publication number
ATE451618T1
ATE451618T1 AT06112423T AT06112423T ATE451618T1 AT E451618 T1 ATE451618 T1 AT E451618T1 AT 06112423 T AT06112423 T AT 06112423T AT 06112423 T AT06112423 T AT 06112423T AT E451618 T1 ATE451618 T1 AT E451618T1
Authority
AT
Austria
Prior art keywords
apr
peptides
immunogenicity
immunogenic
identifying
Prior art date
Application number
AT06112423T
Other languages
English (en)
Inventor
Harald Kropshofer
Anne Vogt
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE451618T1 publication Critical patent/ATE451618T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
AT06112423T 2005-04-20 2006-04-10 Verfahren zur identifizierung von epitopen in zusammenhang mit immunogenität bei biopharmazeutika ATE451618T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05103199 2005-04-20

Publications (1)

Publication Number Publication Date
ATE451618T1 true ATE451618T1 (de) 2009-12-15

Family

ID=37114190

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06112423T ATE451618T1 (de) 2005-04-20 2006-04-10 Verfahren zur identifizierung von epitopen in zusammenhang mit immunogenität bei biopharmazeutika

Country Status (8)

Country Link
US (1) US20060251664A1 (de)
JP (1) JP4275144B2 (de)
CN (1) CN1877336A (de)
AT (1) ATE451618T1 (de)
CA (1) CA2542104C (de)
DE (1) DE602006010934D1 (de)
ES (1) ES2334936T3 (de)
SG (1) SG126893A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008113758A1 (en) * 2007-03-16 2008-09-25 Covalx Ag Direct mass spectrometric analysis of drug candidates targeting protein complexes
GB201121308D0 (en) 2011-12-12 2012-01-25 Cell Medica Ltd Process
WO2016010002A1 (ja) * 2014-07-14 2016-01-21 中外製薬株式会社 タンパク質のエピトープを同定するための方法
JP6999941B2 (ja) * 2015-09-18 2022-02-10 ベイラー カレッジ オブ メディスン 病原体からの免疫原性抗原同定および臨床的有効性との相関
WO2018189148A1 (en) 2017-04-10 2018-10-18 Immatics Biotechnologies Gmbh Peptides and combination thereof for use in the immunotherapy against cancers
CA3059644A1 (en) 2017-04-10 2018-10-18 Immatics Biotechnologies Gmbh Peptides and combination thereof for use in the immunotherapy against cancers
CN112584862A (zh) * 2018-05-17 2021-03-30 伊米若梅有限公司 Ch3结构域表位标签

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60333500D1 (de) * 2002-10-02 2010-09-02 Hoffmann La Roche Verfahren zur Identifizierung antigener Peptide

Also Published As

Publication number Publication date
DE602006010934D1 (de) 2010-01-21
CA2542104A1 (en) 2006-10-20
CA2542104C (en) 2010-12-07
JP2006300945A (ja) 2006-11-02
ES2334936T3 (es) 2010-03-17
JP4275144B2 (ja) 2009-06-10
US20060251664A1 (en) 2006-11-09
CN1877336A (zh) 2006-12-13
SG126893A1 (en) 2006-11-29

Similar Documents

Publication Publication Date Title
ATE451618T1 (de) Verfahren zur identifizierung von epitopen in zusammenhang mit immunogenität bei biopharmazeutika
WO2004063963A3 (en) Novel proteins with altered immunogenicity
NZ591704A (en) Peptide vaccines for cancers expressing tumor-associated antigens
WO2007064919A3 (en) Binding polypeptides with restricted diversity sequences
ATE521708T1 (de) Chimärische, hybrid- und tandem-polypeptide von meningococcus nmb1870
RS52782B (en) HIGH AFINITY HUMAN ANTIBODIES FOR THE HUMAN IL-4 RECEPTOR
MX351502B (es) Anticuerpos de union de albumina y fragmentos de union de los mismos.
EP2534257A4 (de) Verfahren zur identifikation und isolierung von zellen zur expression von polypeptiden
TW200515916A (en) Chimeric antigens for breaking host tolerance to foreign antigens
DE602005021379D1 (de) System und verfahren zur produktion von antikörpern in der pflanzenzellkultur
DE60139542D1 (de) Methoden zur herstellung humaner monoklonaler antikörper
PL2322552T3 (pl) PRZECIWCIAŁA WIĄŻĄCE IL-1β I ICH FRAGMENTY
EA200700136A1 (ru) Анти-cd154-антитела
NZ601615A (en) Antibodies that bind to lysyl oxidase-like 2 (loxl2) and methods of use therefor
MX361076B (es) Proteínas multifunción que comprenden complejo mayor de histocompatibilidad (cmh) de clase i multivalente unido mediante disulfuro.
MY148646A (en) Anti-psgl-1 antibodies
WO2011022077A3 (en) A nucleic acid cassette for producing recombinant antibodies
WO2007146401A3 (en) Denatured collagen peptides and uses thereof
WO2006134190A3 (es) Agentes y métodos basados en el uso del dominio eda de la fibronectina
WO2005012531A3 (en) Antibody cdr polypeptide sequences with restricted diversity
WO2009051555A3 (en) Modified mhc class i binding peptides
EA201100071A1 (ru) Новые композиции и способы
EP4269562A3 (de) Antigenbindende moleküle und verfahren zur verwendung davon
NZ609916A (en) Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof
WO2014144911A3 (en) Hybrid immunoglobulin containing non-peptidyl linkage

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties